Traumatic brain injury (TBI) and other injuries to blood vessels in the brain, like stroke, are a leading cause of long-term disability or death. NINDS researchers have found a possible explanation for why some patients recover much more poorly from brain injury if they later become infected.
Researchers from NCI identified three subtypes of lung cancers in people who never smoked. The results could help guide more precise lung cancer treatments.
A handheld screening device that detects subtle misalignment of the eyes accurately identifies children with amblyopia (lazy eye).
The opioid overdose death rate was significantly higher for non-Hispanic Black individuals in four U.S. states from 2018 to 2019, while the rates for other race and ethnicity groups held steady or decreased. These findings appeared in a new NIH study.
The opioid overdose death rate was significantly higher for non-Hispanic Black individuals in four U.S. states from 2018 to 2019, while the rates for other race and ethnicity groups held steady or decreased.
Equipped with a color 3-D camera, an inertial measurement sensor and its own onboard computer, a newly improved robotic cane could offer blind and visually impaired users a new way to navigate indoors.
A new study lays the groundwork for potential new therapies for progressive multiple sclerosis. Chronic lesions with inflamed rims, or “smoldering” plaques, in the brains of people with MS have been linked to more aggressive and disabling forms of the disease.
Computer tests of attention and focus revealed that older adults declined in 1 one out of 3 key brain functions. The other functions actually improved during aging, at least until the mid-to-late 70s.
An investigational HIV vaccine tested in sub-Saharan Africa posed no safety concerns but did not sufficiently protect against HIV infection.
Researchers from NCI and Washington University School of Medicine have developed a blood test that, they believe, could one day offer a highly sensitive and inexpensive approach to detect cancer early in people with NF1.